NOCIL Revenue Jumps 33% As Volumes Dip; Brokerage Keeps Hold

BROKERAGE-REPORTS
Whalesbook Logo
AuthorKavya Nair|Published at:
NOCIL Revenue Jumps 33% As Volumes Dip; Brokerage Keeps Hold

Rubber chemical producer NOCIL reported a quarterly revenue of ₹4.3 billion, a 33% increase from the previous year. Despite this growth, falling sales volumes and rising costs have led brokerage firm Prabhudas Lilladher to maintain a 'Hold' rating on the stock with a ₹140 target.

NOCIL has reported a quarterly revenue of ₹4.3 billion, a performance that surpassed market expectations and internal projections. While the 33% year-over-year revenue growth appears strong, the company's internal operational data highlights a more challenging scenario. Sales volumes saw a contraction, falling by 3% compared to the same period last year and 7% on a quarter-over-quarter basis.

Revenue Growth vs Volume Contraction

Management has attributed the decline in sales volumes to a combination of logistical disruptions and supply-side constraints, which have been exacerbated by global volatility. While the topline figures reflect higher realization, the underlying volume dip suggests that the company is facing headwinds in maintaining consistent product throughput. The brokerage firm Prabhudas Lilladher has maintained a 'Hold' rating on the stock, citing a cautious outlook on earnings trajectory in the medium term, with a price target set at ₹140.

Expansion Outlook and Operational Risks

Despite the current volume pressures, the company continues to focus on long-term capacity building. The Dahej expansion project is currently advancing as scheduled, which is a key monitorable for future growth. Additionally, the TDQ project is nearing a critical stage, with management expecting to finalize client approvals and commence capitalization in the third quarter of fiscal year 2027. This will likely be followed by a phased commercial ramp-up.

However, operational challenges persist. The company faces stiff competition from imports, which remains a significant factor in the rubber chemicals sector. Furthermore, the firm is contending with elevated costs related to coal, gas, and freight. While anti-dumping duties on certain sulfonamides have provided a marginal improvement to pricing, the overall effect on the bottom line remains limited. Investors may continue to track whether the company can sustain its revenue growth guidance of ₹14 billion to ₹16 billion for the fiscal year while navigating these margin pressures. The ability to increase volumes through the upcoming expansion projects while managing input costs will be critical for future profitability.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.